CymaBay Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q3 2012 to Q4 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
CymaBay Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2012 to Q4 2023.
  • CymaBay Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending December 31, 2023 was 106M shares, a 21% increase year-over-year.
  • CymaBay Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 106M shares, a 21% increase from 2022.
  • CymaBay Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 87.8M shares, a 23.6% increase from 2021.
  • CymaBay Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 71.1M shares.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 106M +18.4M +21% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 106M +17.9M +20.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 102M +14.3M +16.3% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 98M +10.2M +11.6% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 87.8M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 87.8M +18.8M +27.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 87.8M +18.8M +27.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 87.8M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q3 2021 69M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 69M +100K +0.15% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q2 2020 68.9M +187K +0.27% Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-10
Q1 2020 68.9M +6.99M +11.3% Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-11
Q4 2019 67M +9.22M +16% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-16
Q3 2019 68.7M +9.58M +16.2% Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-05
Q2 2019 68.7M +9.86M +16.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 61.9M +8.14M +15.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 57.8M +22.9M +65.6% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 59.1M +19.1M +47.7% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 58.8M +30.1M +105% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 53.8M +27.1M +102% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 34.9M +11.5M +48.9% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-28
Q3 2017 40M +16.6M +70.8% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 28.8M +5.31M +22.6% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 26.6M +3.16M +13.5% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 23.4M +4.55M +24.1% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 23.4M +1.77M +8.18% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 23.4M +8.19M +53.7% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-10
Q1 2016 23.4M +8.35M +55.3% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q4 2015 18.9M +6.85M +56.9% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-23
Q3 2015 21.7M +8.21M +60.9% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 15.3M +5.19M +51.6% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 15.1M +5.23M +52.9% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-11
Q4 2014 12M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-29
Q3 2014 13.5M +13.4M +13188% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 10.1M +10.1M +171978% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-11
Q1 2014 9.87M Jan 2, 2014 Mar 31, 2014 10-Q 2015-05-11
Q3 2013 101K +95.6K +1650% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 5.85K* Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q3 2012 5.79K* Jul 1, 2012 Sep 30, 2012 10-Q/A 2013-12-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.